Skip to main content

Research

Conferences & Presentations

OBRI researchers present findings at leading national and international rheumatology conferences, contributing to the global conversation on real-world arthritis evidence.

2026

CRA 2026

Poster

Defining Difficult-to-Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late D2T-RA Phenotypes

Attar R, Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Kuriya B, Aydin S, on behalf of OBRI Investigators.

Poster

Baseline Predictors of Difficult-To-Treat Rheumatoid Arthritis Across Adapted Definitions: Insights from the OBRI-RA Registry

Attar R, Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Kuriya B, Aydin S, OBRI Investigators.

EULAR 2026

Publication

Impact of Coexisting Gout on Disease Activity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

Kwok T, Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B.

Poster

Defining Difficult-to-Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late D2T-RA Phenotypes

Attar R, Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Kuriya B, Aydin S, OBRI Investigators.

Poster

Cardiorenal–Metabolic Comorbidity and Therapy Eligibility in Rheumatoid Arthritis: Real-World Data from the OBRI

Movahedi M, Seebalack V, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B.

ORA 2026

Oral Presentation

Cardiorenal–Metabolic Comorbidity and Therapy Eligibility in Rheumatoid Arthritis: Real-World Data from the OBRI

Movahedi M, Seebalack V, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B.

ACR 2026

Poster

Cardiorenal–Metabolic Comorbidity and Therapy Eligibility in Rheumatoid Arthritis: Real-World Data from the OBRI

Movahedi M, Seebalack V, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B.

Poster

Oral Glucocorticoid Use and Discontinuation Among JAK Inhibitors and Biologic DMARDs in Rheumatoid Arthritis: A Canadian Retrospective Cohort Study

Movahedi M, Cesta A, Akhavan P, Thorne C, Pope J, Kwok T, Lau A, Mirza R, Hepworth E, Chow A, Aydin S, Kuriya B, OBRI Investigators.

2025

CRA 2025

Poster

A cross-sectional study on predictors of COVID-19 infection, admission and effect of immunomodulating treatments in rheumatoid arthritis

Movahedi M, Hepworth E, Cesta A, Li X, Bombardier C, Aydin S, on behalf of OBRI Investigators.

Poster

Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study

Movahedi M, Cesta A, Li X, Tatangelo M, Bombardier C.

Poster

Hospitalizations, Emergency, Physician visits, Death, and chronic clinical conditions among rheumatoid arthritis patients with and without Herpes Zoster, a retrospective administrative data linked cohort study

Movahedi M, Cesta A, Li X, Tatangelo M, Bombardier C, on behalf of OBRI Investigators.

Poster

The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis, a Real-World Data

Movahedi M, Cesta A, Li X, Kuriya B, Aydin A, Bombardier C, Akhavan P, on behalf of OBRI Investigators.

ORA 2025

Podium Presentation

Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study

Movahedi M, Cesta A, Li X, Tatangelo M, Bombardier C.

ACR 2025

Oral Presentation

Impact of Rheumatoid Arthritis Therapeutic Classes on Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism: A Population-Based Cohort Study

Movahedi M, Cesta A, Akhavan P, Kendzerska T, Aydin S, Bombardier C, Kuriya B.

Poster

Impact of Rheumatoid Arthritis Therapeutic Classes on Risk of All-Cause Mortality and All-Cause Cancer: A Population-Based Cohort Study

Movahedi M, Cesta A, Akhavan P, Kendzerska T, Aydin S, Bombardier C, Kuriya B.

2024

CRA 2024

Poster

The association between disease activity, physical function and anti-rheumatic medication and all-cause mortality in patients with RA, Data from a Rheumatoid Arthritis Registry in Canada

Movahedi M, Cesta A, Li X, Kuriya B, Aydin S, Keystone E, Pope J, Bombardier C.

Poster

Influence of age and sex on disease trajectory in rheumatoid arthritis: Results from the Ontario Best Practices Research Initiative

Boyle J, Cesta A, Mously C, Li X, Kuriya B, Pope J, Keystone E, Bombardier C, Aydin S, Hofstetter C, Movahedi M, OBRI Investigators.

Poster

Improving Outcomes of Patient Living with Psoriatic Arthritis: Results from the Observational Best Practices Research Initiative-Psoriatic Arthritis (OBRI-PsA)

Chow A, Lau A, Soucy E, Movahedi M, Li X, Mously C, Cesta A, Thorne C, Ahluwalia V, Chandran V, Boyle J, Dhillon R, Chan J, Joshi R, Bombardier C, Aydin S.

Poster

Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data

Movahedi M, Choquette D, Coupal L, Keystone E, Bombardier C, Bessette L.

EULAR 2024

Poster

The association between disease activity, physical function and anti-rheumatic medication and all-cause mortality in patients with RA, Data from a Rheumatoid Arthritis Registry in Canada

Movahedi M, Cesta A, Li X, Kuriya B, Aydin S, Keystone E, Pope J, Bombardier C.

Poster

Influence of age and sex on disease trajectory in rheumatoid arthritis: Results from the Ontario Best Practices Research Initiative

Boyle J, Cesta A, Mously C, Li X, Kuriya B, Pope J, Keystone E, Bombardier C, Aydin S, Hofstetter C, Movahedi M, OBRI Investigators.

ORA 2024

Podium Presentation

Healthcare Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study

Movahedi M, Cesta A, Li X, Tatangelo M, Bombardier C.

Podium Presentation

Improving Outcomes of Patient Living with Psoriatic Arthritis: Results from the Observational Best Practices Research Initiative-Psoriatic Arthritis (OBRI-PsA)

Chow A, Lau A, Soucy E, Movahedi M, Li X, Mously C, Cesta A, Thorne C, Ahluwalia V, Chandran V, Boyle J, Dhillon R, Chan J, Joshi R, Bombardier C, Aydin S.

ACR 2024

Poster

Associations between disease activity, physical function and anti-rheumatic medications with all-cause mortality in rheumatoid arthritis (RA): Data from a Canadian RA Registry

Movahedi M, Cesta A, Li X, Kuriya B, Aydin S, Keystone E, Pope J, Bombardier C.

Poster

The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis, a Real-World Data

Movahedi M, Cesta A, Li X, Kuriya B, Aydin S, Bombardier C, Akhavan P, on behalf of OBRI Investigators.

Poster

A cross-sectional study on predictors of COVID-19 infection, admission and mortality and effect of immunomodulating treatments in Rheumatoid Arthritis

Movahedi M, Hepworth E, Cesta A, Li X, Bombardier C, Aydin S, on behalf of OBRI Investigators.

Poster

Healthcare Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study

Movahedi M, Cesta A, Li X, Tatangelo M, Bombardier C.

Conference presentations are updated regularly

For a complete list of OBRI conference presentations or to inquire about upcoming presentations, contact us at Angela.Cesta@uhn.ca.